Skip to Main Content

Paper Details

The Efficacy of Early Additional Hemoperfusion Therapy for Severe COVID-19 Patients: A Prospective Cohort Study.
Blood Purif
7
2022
Author NameAffiliation
Nattachai SrisawatChulalongkorn University
Nattachai SrisawatExcellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital
Nattachai SrisawatCritical Care Nephrology Research Unit, Chulalongkorn University
Nattachai SrisawatAcademy of Science
  • 1 - 4

Datasets

Release 1.2